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 Abstract:  A two reaction synthesis of a urea, using triphos-
gene, was studied. The objective was to transpose the 
process from laboratory scale to pre-industrial plant. 
The whole study was performed in a continuous process, 
adapting the characteristic dimensions and length of the 
reactor. In this paper, the development of the process is 
presented, and the choices about safety and operating 
conditions constraints are discussed. The final operation 
allows a 70% global yield in a 7 week study. Furthermore, 
the use of microreactors not only permits an exhaustive 
study of the process operating parameters, but also pro-
vides feedback on the developed chemistry itself. The 
results obtained are a demonstration of the use of con-
tinuous processes in small scale reactors for complex 
molecule development. The mg · h -1 to kg · h -1 is a key trans-
position in the pharmaceutical industries project develop-
ment, as it can help to accelerate the first lot production 
used in toxicological or pre-clinic stages. 
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1   Introduction, context and 
objectives 
 Process intensification (thanks to miniaturization and 
batch to continuous transposition) opens up numerous 
perspectives in terms of chemical production at an indus-
trial scale [1]. Indeed, decreasing the device size allows a 
reduction of technology constraints to the benefit of chem-
istry [2 – 4]. Continuous microscale devices are character-
ized by high surface to volume areas, which provide them 
with good thermal capacity [5 – 7]. In addition, intensifica-
tion accelerates reaction rates and then reduces reactive 
hold-up. This is of great importance when dealing with 
systems facing safety issues due to hazardous reagents 
[8]. In addition, for the same reasons these technologies, 
often called  “ flow chemistry ” by chemists, are now con-
sidered as real additional tools for the modern chemist 
[9 – 11]. 
 A complete implementation of an intensified system 
often requires an important amount of information on the 
system, including physicochemical parameters, thermoki-
netic models, and thermal and mixing characterization of 
the reactors used [12, 13]. The global objective of this paper 
is to focus on a batch to continuous transposition of the 
synthesis of a urea under industrial constraints. These 
constraints are of two kinds: (i) time and products con-
sumed must be reduced to the minimum, which implies 
that no complete model can be obtained; (ii) the process 
must be transposed in the kilo-lab industrial plant. It is 
a flexible batch-based plant dedicated to the production 
of intermediate product quantities (around the kilogram). 
 The objectives of this paper are: (i) to describe the 
different steps of the transposition from batch to con-
tinuous and from mg · h -1 to kg · h -1 of the production of an 
unsymmetrical urea; (ii) to analyze the experimental 
results obtained in terms of process design and in terms 
of intrinsic chemistry; and (iii) to put into perspective the 
project results in terms of spent time, safety and product 
constraints. 
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1.1   Studied system 
 A brief summary of the synthetic ways explored by the 
Chemical Development Department of Sanofi-Aventis in 
order to produce the urea is given. 
 The studied reactions ( Figure 1 ) correspond to the 
phosgenation of the secondary amine  1 , leading to the car-
bamoyl chloride  2 , followed by the urea  3 formation  via 
the primary amine  4 addition. The proposed urea  3 was 
a pharmaceutical target molecule developed by Sanofi-
Aventis, obtained after a 14 step convergent synthesis. The 
urea formation corresponds to the last one. Optimization 
and scale-up of the latter have thus been considered as an 
important issue for the industrial project. 
 Initially,  2 was formed by adding a phosgene solu-
tion in toluene to  1 . According to the toxicity of this 
reagent, other methodologies have been studied, 
including imidazolide or isopropenyl chloroformate for-
mation attempts, which unfortunately did not produce 
the urea  3 . The pathway  via  2 has been thus reassessed 
by replacing the phosgene solution with the more stable 
analogous triphosgene bis(trichloromethyl) carbonate 
(BTC). During this study, the best results were obtained 
with chlorobenzene as the solvent and diisopropyleth-
ylamine (DIPEA) as the base. For the second reaction, 
Schotten-Baumann conditions from the amine  4 trif-
luoroacetic acid (TFA) salt led to better conversions and 
easier setting up, compared to the reaction in organic 
solvents [dimethylformamide (DMF), toluene, acetoni-
trile] in the presence of DIPEA, but with low reproduc-
ibility and low robustness on extrapolation. 
 Even if the urea could be prepared successfully by 
the previously described method, the targeted produc-
tion on a large scale would be restricted by numerous 
constraints, in particular for the first reaction. Indeed, 
the reaction exothermicity ( Δ 
r
 H = -595 kJ · mol -1 ) and the 
low boiling point of phosgene (8 ° C), require a rigorous 
control of the temperature. Moreover, the use of a BTC 
excess led to the formation of phosgene remaining at 
the end of the reaction, which has to be hydrolyzed by a 
basic treatment. As the goal was to prepare the urea  3 at 
an industrial scale, diminution of phosgene throughput, 
by reducing the reactor volume, was essential and envi-
sioned by transposing the reaction to a continuous 
process. 
1.2   Preliminary analysis and methodology 
developed 
 Firstly, only the first reaction has been studied in chloro-
benzene, and the conditions have been repeated in 
batch to appreciate the reaction behavior. Even if the 
conversion was quite good (93% purity after treatment 
without purification), precipitation of DIPEA chlorhy-
drate and product  2 encourages us to find an alternative 
solvent. While pyridine leads to a rapid consumption of 
 1, along with the production of a large amount of impu-
rities, notably pyridinium salts, dichloromethane had 
a good impurity profile (96% purity after treatment), 
but required a second addition of BTC (0.2 equivalents) 
to achieve completion of the reaction. By lowering the 
DIPEA excess (1.2 instead of 2.5 equivalents), while 
keeping 0.5 BTC equivalent and dichloromethane as the 
solvent, complete consumption of  1 has been observed 
by thin layer chromatography (TLC), but liquid chroma-
tography-mass spectrometry (LC-MS) analysis after treat-
ment has shown the presence of an impurity attributed 
to the trichloromethylcarbamate intermediate  5 . Even if 
it was proposed as the intermediate [14], the observation 
of trichloromethylcarbamate  5 is moreover singular, as 
only a few examples mention the presence of this inter-
mediate during the preparation of ureas from amines and 
BTC. Only three examples show experimental charac-
terizations, one by mass spectroscopy [15] and two by  1 H 
nuclear magnetic resonance (NMR) [16, 17], which do not 
discriminate between the trichloromethylcarbamate and 
the carbamoyl chloride. In other cases, the intermediates 
are not fully characterized [18] or are not isolated [19]. 
Other syntheses are supposed to involve trichloromethyl-
carbamate or carbonate intermediates, but the latter were 
never isolated [20, 21]. 
 The following pathway can thus be proposed 

























 Figure 1   General scheme of urea  3 formation  via the use of triphosgene. 
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2   First experimental step: 
milligrams per hour (mg · h -1 ) 
2.1   Microfluidic device and operating 
conditions for the carbamoyl chloride 2 
formation 
 Because of the possible formation of agglomerates during 
the process, perfluoroalkoxy (PFA) tubes connected with 
polyether ether ketone (PEEK) tee micromixers were 
chosen for practical reasons, as they can be cut and 
replaced easily and inexpensively. To combine classical 
flow velocities (3.33.10 -2 m · s -1 ) for good thermal exchange, 
a length of 8 m, with a residence time of 4 min, was firstly 
investigated (later, the residence time was changed by 
varying the length). 
 The microreactor used was composed of two PFA tube 
reactors  { R 
1
 [inner diameter  φ = 500  μ m, length l = (1 – 8) m, 
R 
2
 [inner diameter  φ = 500  μ m, length l = 1 m] } connected by 
three PEEK tee micromixers (M 
1
 , M 
2
 and M 
3
 , inner diame-
ter = 500  μ m). R 
1
 was used for the phosgenation and R 
2
 for the 
neutralization with NaHCO 
3
 . The whole system ( Figure 3 ) 
was submerged in a controlled temperature bath. The 
reagent solutions were poured in to a glass syringe and 
brought by syringe pumps to the micromixers with flow 
rate control, while the samples were collected in small 
tubes at ambient temperature. 
 In addition to chlorobenzene, dichloromethane 
was also used, as precipitation is avoided with this 
solvent. Experimental operating conditions were: tem-







































 Figure 2   Proposed mechanism for the addition of  1 on BTC in presence of diisopropylethylamine (DIPEA) (path a). Proposed mechanism 











 Figure 3   Schematic view of used set-up for carbamoyl chloride 
formation study. 
0.37 – 0.5; DIPEA equivalent 1.1 – 2.5. In order to restrain 
eventual clogging problems due to precipitation, a dilu-
tion of about 5 compared to batch experiments was used 
in the continuous reactor (about 6 g · l -1 instead of 33 g · l -1 ). 
 Experimental details, including a description of the 
analytical method, are reported in the Appendices Section. 
2.2   Results and discussion 
2.2.1   Preliminary results 
 In dichloromethane, whatever the residence time, DIPEA 
equivalents numbers seem to have no noticeable effect. 
In all cases,  2 was obtained along with  5 in proportions 
of about 55/45. Consumption of  1 increased when the BTC 
equivalent increased and was complete for all values 
over 0.4. 
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 This is in agreement with the previously proposed 
pathway: the first reaction, corresponding to the attack of 
a first amine  1 on BTC, occurs well and very quickly by 
formation of the intermediate  5 along with the release 
of a phosgene molecule. The latter can react promptly 
with a second amine  1 to form the carbamoyl chloride  2 . 
However, the requested time for rearrangement of  5 seems 
to be higher than the residence time. Indeed high-perfor-
mance liquid chromatography (HPLC) analysis of a  2 / 5 
mixture sample obtained at the reactor output, then kept 
for 48 h at 5 ° C, showed a complete conversion into  2 along 
with impurities formation. After 16  h at 5 ° C, conversion 
was, however, incomplete, still with a presence of  5 . 
 In standard chlorobenzene, the total conversion into 
 2 was observed in all cases, except when BTC excess was 
highly reduced without DIPEA stoichiometry adjustment. 
When the concentration was restored to the one used in 
batch conditions (30 g · l -1 in a continuous reactor), a slight 
decline of conversion into  2 was observed (97%), along 
with the occurrence of a small quantity of  5 (3%). 
2.2.2   Influence of water 
 During the experimental conditions study, it appeared 
that the water present in the solvent had an influence on 
the conversion into  2 . Indeed, use of anhydrous chloro-
benzene (dried over molecular sieves) led to a signifi-
cant amount of  5 being obtained, to the detriment of 
the expected  2 (around 20%), whatever the operating 
conditions. 
 In order to validate the water effect on the reaction, the 
latter experiments were undertaken in anhydrous or resat-
urated chlorobenzene (the same chlorobenzene dried over 
a molecular sieve was rehydrated by the addition of water, 
decantation, and then separation). This procedure leads to 
an eventual effect of the molecular sieve. The temperature 
was 20 ° C, the residence time 2 min, the DIPEA equivalent 
from 1.1 to 2.5 and the BTC equivalent from 0.37 to 0.5. 
 Firstly, BTC was introduced in to the anhydrous chlo-
robenzene, while  1 /DIPEA mixture was in a solution in 
anhydrous or resaturated chlorobenzene. Whatever the 
conditions, about 80% of  2 was obtained, along with 
the presence of about 10% of  5 . However, when the BTC 
solution was prepared in resaturated chlorobenzene, the 
conversion into  2 was  > 99%, independent of the nature, 
anhydrous or not, of the  1 /DIPEA solution. It thus seems 
that only the BTC solution needs to be hydrated. 
 Furthermore, various experiments were carried out in 
anhydrous chlorobenzene to promote the conversion of  5 
into  2 . 
 Increasing the quenching solution flow and/or the 
residence time did not have any influence, confirming that 
 5 , once formed, can be converted into  2 only very slowly. 
 Increasing the temperature from 0 ° C to 90 ° C allows 
a complete conversion of  5 into  2 . Table 1 shows the evo-
lution of  5 when the reaction temperature goes from 0 ° C 
(with a conversion into  2 of 67%) to 90 ° C (98% conver-
sion) with a residence time of 5 min, 2.5 DIPEA equivalent 
and 0.5 BTC equivalent. 
 Two conclusions can be drawn from these experi-
ments: (i) the water presence in the solvent has a positive 
influence on the process; (ii) the higher the temperature, 
the faster  5 is converted into  2 . This temperature increase 
also favors the BTC decomposition into phosgene, which 
reacts with  1 to directly yield  2 . 
 On the basis of these results, an alternative pathway 
can be proposed, underlining the role of water in the reac-
tion ( Figure 2 , path b). While the path (a ) corresponds to 
the one previously described, changes are provided with 
path (b ) , in the presence of water. In this case, even before 
the addition of  1 , water contained in the solvent can react 
with BTC which decomposes into phosgene and the corre-
sponding hydrogen carbonate [22]. The latter can  a priori 
be converted into diphosgene in the media (by reacting 
with phosgene, di- or triphosgene or eventually by the 
chlorides present) and can thus react with  1 to give  2 
along with phosgene, immediately consumed to produce 
another molecule of  2 . 
 Whereas BTC is widely described as analogous to 
phosgene [23, 24] (showing a similar behavior), the present 
study in continuous mode has highlighted that its reactiv-
ity can differ depending on the conditions. 
2.3   Coupling the second reaction 
 First preliminary experiments were performed, using the 
same experimental set-up as previously (the last syringe 
containing compound  4 and DIPEA in dichloromethane). 
These experiments show that the characteristic time of 
 Table 1   Effect of temperature on conversion of  1 into  2 in anhydrous 
chlorobenzene (no presence of compound  1 ). 
 Temperature ( ° C)  %1  %2  %5 
 0  0  67.1  32.9 
 20  0  76.0  24.0 
 40  0  81.2  18.8 
 60  0  85.4  14.6 
 80  0  93.2  6.8 
 90  0  98.1  1.9 
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second reaction was  > 2 h and, due to urea  3 precipitation, 
the initial concentration of compound  1 was divided by 
30. These constraints led to the choice of a fed-batch mode 
( Figure 4 ). This choice is not in opposition with the indus-
trialization objective of the work. Indeed, the hazardous 
generation of  2 could occur in a secure continuous reactor, 
while the urea  3 formation could occur in a conventional 
batch reactor containing a solution of  4 and DIPEA. 
 The operating conditions used were: residence time 
in the first reactor was maintained at 2 min (sufficient to 
form  2) ; residence time in the second reactor ranged from 
2 to 1000 min; BTC equivalent of 0.36; DIPEA equivalent of 
1.08. Each sample corresponded to a 2 min reactor output 
pouring into a hemolysis tube containing  4 (1.2 equiva-
lents) and DIPEA (1.2 equivalents) in dichloromethane, 
chlorobenzene or acetonitrile. 
 A kinetic study of the second reaction was undertaken 
in these conditions for different solvents. Experimental 
details are reported in the Appendices section. 
 Figure 5 shows the results of this study. 
 Conversion into  3 was much faster in acetonitrile than 
in dichloromethane (96% vs. 42% after 40 min). In chloro-
benzene, the reaction seemed even slower, with a conver-
sion reaching only 10% after 16 h. 
 Acetonitrile was thus chosen to implement the second 
reaction for the following steps of the study. 
3   Second experimental step: 
ten grams per hour (10 g · h -1 ) 
3.1   Experimental methods 
 As mentioned in the previous scale, in order to respect 
the industrial objectives, fed-batch mode was conserved 
for the second reaction. Thus, only reactor tube length 
(along with flow rate adjustments) was increased, while 
the other parameters were kept unchanged (reactor inner 
diameter, concentration), so as to minimize scale change 
impact. Temperature and DIPEA equivalent were kept to 
20 ° C and 1.2, respectively. The initial concentration of 
 1 was 22 g · l -1 . Commercial non dried chlorobenzene was 
used as the solvent. 
 Owing to the flow rates and volumes proposed, 
the introduction of the reagents was ensured by HPLC 
pumps. A three way valve was installed at the contin-
uous reactor. It allows to send the output flow either 
toward a  “ waste ” Erlenmeyer during the stationary state, 
or toward the Erlenmeyer containing the  4 and DIPEA 
solution ( Figure 6 ). 
 Concerning the first reaction (in continuous mode), 
as the reactor length was elongated to 30 m instead of 
1 m, while reducing the residence time to 1 – 2 min, the 
flow velocity was increased to 0.25 – 0.5 m · s -1 instead of 
0.0083 m · s -1 , resulting  a priori in a better heat transfer. 
However, contrary to syringe pumps used at the micro-
scale, HPLC pumps may cause flow rate oscillation. 
 For the second reaction, as it is conducted in batch 
mode, elongation of the addition time induced initial and 
local stoichiometry changes, resulting in a strong  4 excess 
at the beginning of the addition (the addition time is 10 
min). In the batch reactor, with a magnetically stirred 
Erlenmeyer, the mixing efficiency may decrease, while 
thermal effects changes are difficult to predict. 
 Experimental details are reported in the Appendices 
section. 
3.2   Results and discussion 
 Firstly, generation of the carbamoyl chloride  2 was studied 
by using 10 min output flow of the continuous reactor into 
a quenching solution placed in the Erlenmeyer. Results 
are presented in Table 2. 
 A first test showed a good conversion of  1 into  2 , but 
 5 was also produced (about 10%). Increasing BTC equiva-
lents or the residence time did not lead to any improve-
ment. In addition, no impact was observed with the use of 
chlorobenzene saturated with water for the preparation of 
BTC solution. 
 The second reaction was performed according to the 
previously described method. Experiments, correspond-
ing to two 20  min additions into the  4 solution, were 
achieved. DIPEA stoichiometry used for the first step 
study was kept (1.2 equivalents). While a new unattrib-
uted impurity was detected in a low quantity after 5 min, 
with finally, complete disappearance, the conversion into 
 3 was 48% after 5 min and increased slowly to 55% after 








 Figure 4   Schematic view of fed-batch system used for the two 
steps sequence study. 
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 Two hypotheses can be proposed to explain the pres-
ence of  5 : 
 –  Flow speed increase in the reactor (0.5 m · s -1 instead 
of 0.0083 m · s -1 ), resulting in a better heat transfer; a 
temperature increase could thus be avoided in these 
conditions. As shown previously, temperature is 
favorable to the decomposition of  5 into  2 . The good 
thermal performances of the continuous mode at a 
small reactor scale should be unfavorable. 
 –  Poorly controlled stoichiometry at the tee micro-
mixer, due to flow oscillation generated by the HPLC 
pumps. 
 Concerning the second reaction, the observed maximum 
at 55% can be explained by protonation of  4 (as was men-
tioned during the first step of the study). In addition, the 



























 Figure 5   Effect of residence time in fed-batch mode on conversion of  1 into  3 . (20 ° C; R 
1
 : l = 1 m,  φ = 500  μ m,  τ = 2 min,  v = 8.33.10 -3 m · s -1 , 0.098 
ml · min -1 , [ 1 ] = ~33 g · l -1 in chlorobenzene, 0.36 eq. BTC, 1.08 eq. DIPEA). 
 Table 2   Study of the conversion of  1 into  2 at about 10 g · h -1 . 
 Residence time (min)  BTC eq.  % 1  % 2  % 5 
 1  0.4  3.5  87.6  8.2 
 1  0.4  3.9  87.3  8.3 
 1  0.4  3.4  87.3  8.5 
 1  0.5  3.9  87.5  7.8 
 1  0.5  4.8  86.5  7.9 
 1.5  0.4  3.7  87.8  8.0 
 2  0.4  3.4  82.8  7.12 
 2  0.4  3.5  88.1  7.8 
 1  0.36  3.0  85.1  10.8 
 Table 3   Conversion of  1 into  3 study at about 10 g · h -1 . 
 Time in batch reactor (min)  %  1  %  2  %  3  %  5  % n.i.p 
 5  1.4  38.1  47.9  11.0  1.6 
 35  1.2  32.9  53.7  10.9  1.3 
 50  1.2  32.5  54.7  10.9  0.7 
 150  0  33.0  55.5  11.5  0 
n.i.p., correspond to non identified product.
proportions at the end of the second reaction as  5 is not 
involved in the second reaction. 
 In conclusion, novel difficulties appeared with this first 
scale-up: the presence of an impurity which slowly disap-
pears, enhancement of the formation of  5 and limitation of 
conversion into  3 . However, the results allow reaching the 
kilo-lab industrial production plant without further experi-
ments. Analysis of these intermediate scale results provide 
interesting points to work on for further process studies (the 
temperature level at the very beginning of the first reaction 
and local stoichiometry and mixing for the second one.). 
4   Third experimental step: 
kilos per hour (kg · h -1 ) 
4.1   Experimental methods 
 For kilo-lab implementation, a new scale-up was neces-
sary: in addition to the reactor tube length, the inner 
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diameter was also increased (1.55 mm instead of 0.5 mm). 
The reactor made out of the tubing was wrapped around 
a stainless steel bar to assure thermal behavior. Then, for 
safety reasons, the reactor was submerged in a 20% soda 
bath. 
 1 /DIPEA solution was introduced with a gear pump, 
while the BTC solution was delivered by a PTFE peristal-
tic pump to avoid corrosion. The reactor length was 20 m 
(instead of 30 m in previous study), to conform to the limi-
tations of the pump and to reduce the fluid velocity. 
 During steady state establishment, the reactor output 
was redirected to a  “ waste ” reactor containing soda solu-
tion  via a three way valve. In addition, another three way 
valve was installed at the continuous reactor output, 
allowing collection of the sample for analysis before intro-
duction into the reactor containing the  4 /DIPEA solu-
tion. The scheme of the installation is the same as shown 
in  Figure 6 (with 100 l stirred tank reactors instead of 
Erlenmeyers). 
 Modifications are expected on system behaviors due 
to technological choices. The reactor was shortened to 
20  m and the inner diameter was increased to 1.55 mm. 
Then, the flow velocity is slightly lower (0.33 m · s -1 instead 
0.5 m · s -1 ), to maintain heat transfer efficiency. The most 
important, is the modification of the inner diameter, 
which may increase mixing and heat transfer character-
istic times. Oscillation of flow rates could also happen 
because of the used pumps, in particular with the peri-
staltic pump (flow oscillation amplitudes were about 20% 
with the peristaltic pump and 5% with the gear pump). 
 The same expectations as for the first scale-up are 
also available for the second reaction in batch, namely, 
change of initial and local stoichiometry and modification 
of thermal effects, while mechanical stirring of the reactor 
should enhance the mixing efficiency. 
 Experimental details are reported in the Appendices 
section. 
4.2   Results and discussion 
 According to the allowed time (the industrial kilo-lab 
plant was stopped for the study), only a 1 day experiment 
was planned, corresponding to the optimal conditions: in 
chlorobenzene saturated with water as the solvent, 0.36 
BTC equivalents and 1.08 DIPEA equivalents for the first 
reaction (generation of  2) were used. Then, the continuous 
reactor output was fed into the batch reactor containing the 
 4 /DIPEA solution in acetonitrile. The addition was stopped 
after 5 h of feeding (to reach stoichiometry) and the reactor 
stayed in stirring mode under temperature control. 
 The analysis between 1h 45 min and 6 h 10 min after 
steady state was reached in the continuous part, showed 
a very weak conversion progress, with a limitation at 70% 
(see Table 4). A significant amount of  5 was also detected 
(about 15 – 20%), but disappeared after 72 h in favor of  2 , 
suggesting that  5 had been converted slowly into  2 . 
 However, the observed stagnation of conversion into  3 
can be explained by two phenomena: 
 –  Inhibition of reactivity of  4 left in the media, due to 
its protonation, was also observed during the second 
scale study. The increase in reaction time allowed this 
acid-base equilibrium. 
 –  Consumption of  4  via reaction with the generated 
phosgene during  5 degradation, to form an isocyanate 
suitable for leading to a symmetrical urea by addition 
of another  4 molecule. 
5   Conclusion 
 The objective of the project was to implement a two step 
synthesis of an unsymmetrical urea, using triphosgene 
as a phosgenation agent. Classically implemented in a 
batch reactor at lab-scale, the transposition to the indus-
trial kilo-lab production plant was not directly possible for 
safety reasons, due to phosgene. Indeed, the equivalent 
batch reactor volume necessary to produce a kilo of prod-
ucts involved too much phosgene. A continuous process 
was then identified as a possible way to solve this issue. 
 Therefore, the objective of the study was to implement 
a continuous process with a constraint of time and quan-
tity used for the preliminary experiments. Two process 
scales were studied (mg · h -1 and 10 g · h -1 ) before the final 
scale (kg · h -1 ). Because of the exothermic reactions and 
very low characteristic times of reaction, a submillimetric 
scale was chosen for the first reactors. 
 The lab-scale study (mg · h -1 , in a 1 – 8 m long tube with 
a diameter of 500  μ m) gives information on the influence 
of the operating parameters on the process and choice of 
a functioning point for the scale-up. Furthermore, this 
 Table 4   Conversion of  1 into  3 at kilo-lab scale. 
 Time in batch reactor  %  1  %  2  %  3  %  5  % n.i.p. 
 1 h 45 min  2.65  1.33  65.78  15.77  14.47 
 3 h 33 min  2.94  7.24  65.53  19.51  4.78 
 3 h 47 min  3.01  6.84  65.3  19.43  5.42 
 5 h  2.88  4.03  69.18  18.22  5.69 
 6 h 10 min  2.86  2.69  70.47  17.04  6.94 
 72 h  2.6  13.44  71  0.42  12.54 
n.i.p., correspond to non identified product.
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study offers the possibility of feedback on the knowledge 
of the reaction mechanism. 
 An intermediate scale was implemented by only 
increasing the length of the reactor and adjusting the 
flow rates to maintain the residence time. This  “ smart 
scale-up ” allows a 10 g · h -1 production to be reached, 
without increasing the risks. Indeed, the main influence 
was on the velocity of the fluids in the tubing, which 
enhanced mixing and heat transfer efficiency. Such var-
iations lead to a better control of the process parameters 
in the reactor. The parameters study confirms the previ-
ous conclusion and the change in scale allows amelio-
ration points of the process itself to be defined. Finally, 
the reactive volume involved was inferior to 6 ml, which 
is an acceptable volume for safety implementation in 
the lab. 
 The kilo per hour scale was implemented in a contin-
uous process in a larger tube. The phosgenation occurs in 
less than 100 ml, which implies small holdup of phosgene. 
Even if the obtained results (final product concentration) 
are lower than the ones obtained in the first step of the 
study (g · h -1 ), it is important to notice that the operation 
should have been impossible to carry out in batch con-
ditions, because of the considerable amount of BTC: the 
continuous process involved about 10 -3 mol of potentially 
available phosgene from BTC. By comparison, to reach the 
same production in an 8 h period, the batch reactor would 
have required 1 mol available phosgene at the operation 
start up. 
 Even if a better yield (84.8% from  1 ) had been reached 
in the pure batch reactor for production  via the  5 inter-
mediate (scale-up led to a worse result: 70%), the yield 
from  4 was better by using the continuous process (60% 
instead of 57.2% or even 47%). As the primary amine  4 
was difficult to produce and expensive, the continuous 
process seems to be a consistent alternative for the urea  3 
production. The pilot is now ready to be used for optimiza-
tion of operating conditions. 
 Finally, the whole project was analyzed in terms of 
time scheduling; all durations included analytical treat-
ment of the samples, a safety analysis procedure and 
development of start-up procedures (Table 5). 
 The obtained results are a convincing demonstration 
of the use of continuous processes in small scale reactors 
for complex molecule development. The mg · h -1 to kg · h -1 is a 
key transposition in the pharmaceutical industries project 
development, as it can help to accelerate the first produc-
tion used in toxicological or pre-clinic steps. Furthermore, 
the use of a microreactor for the first steps of the study not 
only permits an exhaustive study of the process operating 
parameters, but also provides important feedback on the 
developed chemistry itself. 
 Beyond the transposition results under industrial con-
straints, a very important point lies in the results obtained 
on the chemical pathway during the project. This under-
lines the importance of associating chemistry and chemi-
cal engineering specialists around the  “ flow chemistry ” 
tools. Both communities drive the project using their own 
point of view and concepts and this allows them to fully 
capitalize on the advantages of continuous submillimetric 
systems. 
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 Table 5   Project timing description. 
 Batch first tests, analytical method transfer, solvent influence and products solubilities  1 week 
 Continuous transposition, complete study on operating parameters influence (reagents stoichiometry, temperature, 
residence time) on the reactions yields 
 2 weeks 
 Specific study on the water influence on the first reaction and mechanistic study  1 week 
 Intermediate scale transposition, complete study on operating parameters influence (reagents stoichiometry, temperature, 
residence time) on the reactions yields 
 2 weeks 
 Kilo-lab production plant transposition, preparation for the 1 day experiment  1 week 
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 Appendices 
 Analytical methods 
 After collecting, the organic phase was removed and con-
centrated under reduced pressure, then diluted with ace-
tonitrile for the HPLC analysis. When chlorobenzene was 
used as reaction solvent, a first addition of dichlorometh-
ane was required to separate the organic phase prior to 
the previous treatment. As no purification was performed, 
NMR was difficult to interpret and only HPLC and LC-MS 
were used to control the reactor output. The UV-visible cal-
ibration for HPLC showed that the compounds  1 ,  2 and  5 
exhibited similar absorbencies, and conversion of  1 – 2 and 
the proportion of  5 could be determined. An attempt to 
follow the reaction by RAMAN ended in failure due to the 
poor differences between  1 ,  2 and  5 emission spectrums. 
The infrared (IR) spectroscopy was also envisioned as an 
inline control method, but time and logistical constraints 
dissuaded us from going into detail with this system. 
 Batch syntheses 
 4-(5-(4-(tert-butyl)piperazin-1-yl)pyridin-2-yl)-3,4-dihydro-
quinoxaline-1(2H)-carbonyle chloride (CC) synthesis: 
 Path A : A solution in chlorobenzene (70 ml) of  1 (3.0 g, 
8.53 mmol) and DIPEA (3.73 ml, 21.34 mmol), heated for 
10  min at 35 ° C in order to get a homogeneous media, 
was been dropped (within 1 h) on a triphosgene solution 
(1.27 g, 4.27 mmol) in chlorobenzene (20 ml) at 0 – 2 ° C. 
After 2  h of stirring at ambient temperature, a NaHCO 
3
 
solution (40  ml of saturated solution  + 20  ml water) was 
added to the beige obtained suspension. After extraction 
with dichloromethane, organic phases were washed with 
water, dried over MgSO 
4
 then concentrated to give a beige 
solid (3.43 g, 97%). 
 Path B : A solution in dichloromethane (30 ml) of  1 
(3.0 g, 8.53 mmol) and DIPEA (3.73 ml, 21.34 mmol) was 
dropped (within 45 min) on a triphosgene solution (1.27 
g, 4.27 mmol) in dichloromethane (15 ml) at 0 – 2 ° C. After 
15 min at 0 ° C, then 4 h at ambient temperature, HPLC ana-
lysis showed the presence of the quinoxaline derivative, 
without any changes. A triphosgene solution (0.51 g, 1.71 
mmol) in dichloromethane (10 ml) was thus added at 0 ° C. 
Stirring was maintained for 30 min at ambient temperature 
(reaction ended according to TLC), then a NaHCO 
3
 solution 
(40 ml saturated solution  + 20 ml water) was added to the 
brown obtained solution. After extraction with dichlo-
romethane, the organic phases were washed with water, 
dried over MgSO 
4
 then concentrated to give a beige solid. 
 Path C : A solution in dichloromethane (30 ml) of  1 (3.0 
g, 8.53 mmol) and pyridine (1.73 ml, 21.34 mmol) was been 
dropped (within 20 min) on a triphosgene solution (1.27 
g, 4.27 mmol) in dichloromethane (20 ml) at 0 – 2 ° C. The 
solution became instantaneously yellow, then orange, 
and finally red-orange. After 20 min at 0 ° C, TLC analysis 
showed that the reaction had ended, and a NaHCO 
3
 solu-
tion (40 ml saturated solution  + 20 ml water) was added 
to the reactive media. After extraction with dichlorometh-
ane, the organic phases were washed with water, dried 
over MgSO 
4
 then concentrated to give a foamy red solid. 
 Continuous syntheses at mg · h -1 
 Continuous system constitution 
 A microflow system consisting of three PEEK T-shaped 
micromixers (M 
1
 , M 
2
 and M 
3
 , inner diameter = 500  μ m) 
and two PFA tube reactors [R 
1
 (inner diameter  φ = 500  μ m, 
length l = 1 m), R 
2
 (inner diameter  φ = 500  μ m, length l = 1 m)] 
was used. The whole system was placed in a heated bath 




 solution. The solutions were brought 
by syringe pumps. 
 General procedure for  2 formation study 
 A solution of  1 (500 mg, 1.422 mmol, 0.1422  m in chlo-
robenzene, 3.850 ml · h -1 ) and a solution of DIPEA (220.6 
mg, 1.707 mmol, 0.743  m in chlorobenzene, 1.2 eq., 0.885 
ml · h -1 ) were introduced into M 
1
 , then the resulting mix-
tures were mixed with a BTC solution (168.8 mg, 0.569 
mmol, 0.1897 M in chlorobenzene, 0.4 eq., 1.155 ml · h -1 ) in 
M 
2
 . The resulting solution was passed through R 
1
 into M 
3
 , 
where the solution was mixed with a quenching NaHCO 
3
 
solution (4 ml · h -1 ); then the biphasic mixture was passed 
through R 
2
 . After steady state was reached, the samples 
were collected in hemolysis tubes (2 min for each sample). 
After addition of dichloromethane in order to facilitate the 
phases separation, the organic phase was removed, con-
centrated (not to dryness), then diluted with acetonitrile 
for the HPLC analysis. 
 General procedure for  3 formation study 
 A solution of  1 (500 mg, 1.422 mmol, 0.1422  m in chloroben-
zene, 3.850 ml · h -1 ) and a solution of DIPEA (220.6 mg, 1.707 
mmol, 0.7428  m in chlorobenzene, 1.2 eq., 0.885 ml · h -1 ) 
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were introduced into M 
1
 , then the resulting mixtures were 
mixed with a BTC solution (168.8 mg, 0.569 mmol, 0.1897  m 
in chlorobenzene, 0.4 eq., 1.155 ml · h -1 ) in M 
2
 . The resulting 
solution was passed through R 
1
 into M 
3
 , where the solu-
tion was mixed with a solution of  4 (331.6 mg, 1.707 mmol, 
1.2 eq.) and DIPEA (220.6 mg, 1.707 mmol, 1.2 eq.) in ace-
tonitrile (10 ml, 3.850 ml · h -1 ), then the resulting solution 
was passed through R 
2
 . After steady state was reached, the 
samples were collected in hemolysis tubes (2 min for each 
sample). After dilution with acetonitrile, the samples were 
analyzed by HPLC. 
 Continuous syntheses at g · h -1 
 Continuous system constitution 
 A microflow system consisting of 1 PEEK T-shaped 
micromixer M 
1
 (inner diameter = 500  μ m) and 1 PFA tube 
reactor R 
1
 (inner diameter  φ = 500  μ m, length l = 30 m) was 





 solution. The solutions were brought by HPLC 
pumps. 
 General procedure for 2 formation study 
 A solution of  1 (52.80 g, 150.2 mmol) and DIPEA (23.30 g, 
180.3 mmol, 1.2 eq.) in chlorobenzene (1.6 l, 237.145 ml · h -1 ) 
was mixed with a BTC solution (4.46 g, 15.0 mmol, 0.4 eq., 





 the resulting solution was passed through R 
1.
 After 
steady state was reached (before that, a three way valve 
redirected the reactor output into a  “ waste ” Erlenmeyer 
containing a saturated NaHCO 
3
 solution), the mixture was 
added during 5 min on a quenching NaHCO 
3
 solution (50 
ml) in an Erlenmeyer, under magnetic stirring. Aliquots 
from the organic phase were taken, diluted with acetoni-
trile and then analyzed by HPLC. 
 General procedure for  3 formation study 
 A solution of  1 (52.80 g, 150.2 mmol) and DIPEA (23.30 g, 
180.3 mmol, 1.2 eq.) in chlorobenzene (1.6 l, 224.628 ml · h -1 ) 
was mixed with a BTC solution (2.23 g, 7.51 mmol, 0.36 eq., 





 the resulting solution was passed through R 
1.
 After 
steady state was reached (before that, a three way valve 
redirected the reactor output into a  “ waste ” Erlenmeyer 
containing a saturated NaHCO 
3
 solution), the mixture was 
added during 20 min on a solution of  4 (1.61 g, 8.27 mmol, 
1.2 eq.) and DIPEA (1.07 g, 8.27 mmol, 1.2 eq.) in acetoni-
trile (220 ml) in an Erlenmeyer, under magnetic stirring. 
Aliquots from the organic phase were taken after 5, 35, 50 
and 150 min, diluted with acetonitrile and then analyzed 
by HPLC. 
 Continuous syntheses at kilo-lab industrial 
plant 
 Continuous system constitution 
 A continuous flow system consisting of one PEEK T-shaped 
micromixer M 
1
 and one PFA tube reactor R 
1
 (inner diam-
eter  φ = 1.55 mm, length l = 20 m) was used. The reactor and 
micromixer were placed in a bath containing a 20% soda 
solution. The  1 /DIPEA solution was introduced by a gear 
pump, while the BTC solution was brought by a peristaltic 
pump. 
 Procedure for  2 formation study 
 A solution of  1 (254.1 g, 723 mmol) and DIPEA (100.9 g, 
780 mmol, 1.08 eq.) in chlorobenzene (7.305 l, 1540.00 
ml · h -1 ) was mixed with a BTC solution (77.23 g, 260 mmol, 
0.36 eq., 0.069  m in chlorobenzene, 3.773 l, 769.97 ml · h -1 ) 
into M 
1
 , then 
 
 the resulting solution was passed through 
R 
1
 (59 s, 2309.97 ml · h -1 , 0.34 m · s -1 ) 
.
 After steady state was 
reached (during that, a three way valve redirected the 
reactor output into a  “ waste ” reactor containing a 20% 
soda solution), an aliquot was taken at the continuous 





 solution. The organic phase was taken, diluted with 
acetonitrile and then analyzed by HPLC. 
 Procedure for 3 formation study 
 A solution of  1 (254.1 g, 723 mmol) and DIPEA (100.9 g, 
780 mmol, 1.08 eq.) in chlorobenzene (7.305 l, 1540.00 
ml · h -1 ) was mixed with a BTC solution (77.23 g, 260 mmol, 
0.36 eq., 0.069  m in chlorobenzene, 3.773 l, 769.97 ml · h -1 ) 
into M 
1
 , then 
 
 the resulting solution was passed through 
R 
1
 (59 s, 2309.97 ml · h -1 , 0.34 m · s -1 ) 
.
 After steady state was 
reached (before that, a three way valve redirected the 
reactor output into a  “ waste ” reactor containing a 20% 
soda solution), the mixture was added during 5  h on a 
solution of  4 (208.46 g, 867 mmol, 1.2 eq.) and DIPEA 
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(112.12 g, 870 mmol, 1.2 eq.) in acetonitrile (31.697 l) in 
a reactor, under mechanical stirring. Aliquots from the 
organic phase were taken during the addition (1 h 45 min, 
3 h 33 min, 3 h 45 min), at the end of addition (5 h), and 
after 6 h 10 min and 72 h, diluted with acetonitrile and 
then analyzed by HPLC. 
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